Psoríase Brasil

Union of Carriers Associations of Psoriasis

Psoriasis Brazil – Brazilian Association of Psoriasis, Psoriatic Arthritis and other Chronic Skin Diseases – has as its main objective to fight for patients' rights in accessing public health policies and to disseminate information relating to psoriatic disease and other chronic skin diseases. Psoriasis Brazil is a national non-profit entity, founded in 2005, with headquarters in Porto Alegre (RS).

The organization's work on psoriatic disease is based on the Global Psoriasis Report, prepared by the World Health Organization (WHO) in 2014, together with its Resolution on Psoriasis, of which Brazil is a signatory.

Psoriasis Brazil's mission is to seek universal access to diagnosis and treatment of diseases, whether within the scope of the Unified Health System (SUS) or through private health plans (ANS). To this end, they advocate with parliamentarians and other levels of public and private administration. Since 2020, new chronic skin diseases have been incorporated into the cause of psoriatic disease, such as chronic spontaneous urticaria, atopic dermatitis and vitiligo.

Psoriase Brasil develops its work absolutely autonomously, seeking partnership in carrying out specific projects. We have a team of specialist doctors who work voluntarily to help us with the cause.

Mission
Inform, clarify and raise awareness among civil society about psoriasis, psoriatic arthritis and other chronic skin diseases. Defend and guarantee patients’ rights through actions that result in improved quality of life. Act in advocacy to defend health before the Public Authorities in all instances, especially for the promotion of health and access to treatments.

Vision
To be an association of people with psoriasis, psoriatic arthritis and other chronic skin diseases in Brazil.

PSORIASIS IN NUMBERS

2.6 million Brazilians live with psoriatic disease.

In Brazil, the ethnic composition, increased longevity, in addition to climatic and insolation characteristics may imply unique epidemiological data and different regional prevalence rates of psoriasis, in addition to influence disease severity and therapeutic response.

Brazil has made significant strides in providing access to psoriasis treatments. The Unified Health System (SUS) offers several treatment options, including topical therapies, phototherapy, and biologic drugs. However, access to specialized care can still be limited in rural areas​